List of works - Luca Longo

A genome-wide microRNA profiling indicates miR-424-5p and miR-503-5p as regulators of ALK expression in neuroblastoma.

scientific article published on 11 April 2017

A high-content screening of anti-cancer compounds suggests the multiple tyrosine kinase inhibitor ponatinib for repurposing in neuroblastoma therapy.

scientific article

An 18 gene expression-based score classifier predicts the clinical outcome in stage 4 neuroblastoma.

scientific article published on 17 May 2016

Autophagy inhibition improves the cytotoxic effects of receptor tyrosine kinase inhibitors.

scientific article

Co-Administration of Fendiline Hydrochloride Enhances Chemotherapeutic Efficacy of Cisplatin in Neuroblastoma Treatment

scientific article published on 10 November 2020

Combined therapeutic effects of vinblastine and rapamycin on human neuroblastoma growth, apoptosis, and angiogenesis

scientific article

Exome and deep sequencing of clinically aggressive neuroblastoma reveal somatic mutations that affect key pathways involved in cancer progression

scientific article published on 18 March 2016

Familial neuroblastoma: a complex heritable disease.

scientific article

Genetic Predisposition to Familial Neuroblastoma: Identification of Two Novel Genomic Regions at 2p and 12p

scientific article published on 22 February 2007

Genetic abnormalities in adolescents and young adults with neuroblastoma: A report from the Italian Neuroblastoma group

scientific article published on 29 April 2015

Genome analysis and gene expression profiling of neuroblastoma and ganglioneuroblastoma reveal differences between neuroblastic and Schwannian stromal cells

scientific article published in November 2005

Genome-Wide Linkage Analysis to Identify Genetic Modifiers of <i>ALK</i> Mutation Penetrance in Familial Neuroblastoma ⬇️

scientific article published on July 6, 2011

High-resolution array CGH profiling identifies Na/K transporting ATPase interacting 2 (NKAIN2) as a predisposing candidate gene in neuroblastoma

scientific article

Identification of ALK as a major familial neuroblastoma predisposition gene

scientific article

Identification of ALK germline mutation (3605delG) in pediatric anaplastic medulloblastoma.

scientific article published on 19 July 2012

Identification of GALNT14 as a novel neuroblastoma predisposition gene

scientific article published on 3 July 2015

Impact of interleukin-6 -174 G>C gene promoter polymorphism on neuroblastoma

scientific article

Inhibition of N-linked glycosylation impairs ALK phosphorylation and disrupts pro-survival signaling in neuroblastoma cell lines ⬇️

scientific article published on December 22, 2011

Mutation-independent anaplastic lymphoma kinase overexpression in poor prognosis neuroblastoma patients

scientific article

NAC, tiron and trolox impair survival of cell cultures containing glioblastoma tumorigenic initiating cells by inhibition of cell cycle progression.

scientific article

Oligogenic inheritance in neuroblastoma

scientific article published on 01 October 2005

PHOX2B mutations and genetic predisposition to neuroblastoma

Perhexiline maleate enhances antitumor efficacy of cisplatin in neuroblastoma by inducing over-expression of NDM29 ncRNA.

scientific article

Precision Medicine for NSCLC in the Era of Immunotherapy: New Biomarkers to Select the Most Suitable Treatment or the Most Suitable Patient

scientific article published on 30 April 2020

Proteomic analysis uncovers common effects of IFN-γ and IL-27 on the HLA class I antigen presentation machinery in human cancer cells.

scientific article published on 24 September 2016

Radiomic detection of EGFR mutations in NSCLC

scientific article published on 04 November 2020

Replication of GWAS-identified neuroblastoma risk loci strengthens the role of BARD1 and affirms the cumulative effect of genetic variations on disease susceptibility

scientific article published on 07 December 2012

Role of CXCL13-CXCR5 crosstalk between malignant neuroblastoma cells and Schwannian stromal cells in neuroblastic tumors.

scientific article

Two regions of deletion in 9p22- p24 in neuroblastoma are frequently observed in favorable tumors

scientific article published on 01 May 2002

Weak linkage at 4p16 to predisposition for human neuroblastoma

scientific article published on 01 November 2002

List of works by Luca Longo

A genome-wide microRNA profiling indicates miR-424-5p and miR-503-5p as regulators of ALK expression in neuroblastoma.

A high-content screening of anti-cancer compounds suggests the multiple tyrosine kinase inhibitor ponatinib for repurposing in neuroblastoma therapy.

An 18 gene expression-based score classifier predicts the clinical outcome in stage 4 neuroblastoma.

Autophagy inhibition improves the cytotoxic effects of receptor tyrosine kinase inhibitors.

Co-Administration of Fendiline Hydrochloride Enhances Chemotherapeutic Efficacy of Cisplatin in Neuroblastoma Treatment

Combined therapeutic effects of vinblastine and rapamycin on human neuroblastoma growth, apoptosis, and angiogenesis

Exome and deep sequencing of clinically aggressive neuroblastoma reveal somatic mutations that affect key pathways involved in cancer progression

Familial neuroblastoma: a complex heritable disease.

Genetic Predisposition to Familial Neuroblastoma: Identification of Two Novel Genomic Regions at 2p and 12p

Genetic abnormalities in adolescents and young adults with neuroblastoma: A report from the Italian Neuroblastoma group

Genome analysis and gene expression profiling of neuroblastoma and ganglioneuroblastoma reveal differences between neuroblastic and Schwannian stromal cells

Genome-Wide Linkage Analysis to Identify Genetic Modifiers of &lt;i&gt;ALK&lt;/i&gt; Mutation Penetrance in Familial Neuroblastoma ⬇️

High-resolution array CGH profiling identifies Na/K transporting ATPase interacting 2 (NKAIN2) as a predisposing candidate gene in neuroblastoma

Identification of ALK as a major familial neuroblastoma predisposition gene

Identification of ALK germline mutation (3605delG) in pediatric anaplastic medulloblastoma.

Identification of GALNT14 as a novel neuroblastoma predisposition gene

Impact of interleukin-6 -174 G>C gene promoter polymorphism on neuroblastoma

Inhibition of N-linked glycosylation impairs ALK phosphorylation and disrupts pro-survival signaling in neuroblastoma cell lines ⬇️

Mutation-independent anaplastic lymphoma kinase overexpression in poor prognosis neuroblastoma patients

NAC, tiron and trolox impair survival of cell cultures containing glioblastoma tumorigenic initiating cells by inhibition of cell cycle progression.

Oligogenic inheritance in neuroblastoma

PHOX2B mutations and genetic predisposition to neuroblastoma

Perhexiline maleate enhances antitumor efficacy of cisplatin in neuroblastoma by inducing over-expression of NDM29 ncRNA.

Precision Medicine for NSCLC in the Era of Immunotherapy: New Biomarkers to Select the Most Suitable Treatment or the Most Suitable Patient

Proteomic analysis uncovers common effects of IFN-γ and IL-27 on the HLA class I antigen presentation machinery in human cancer cells.

Radiomic detection of EGFR mutations in NSCLC

Replication of GWAS-identified neuroblastoma risk loci strengthens the role of BARD1 and affirms the cumulative effect of genetic variations on disease susceptibility

Role of CXCL13-CXCR5 crosstalk between malignant neuroblastoma cells and Schwannian stromal cells in neuroblastic tumors.

Two regions of deletion in 9p22- p24 in neuroblastoma are frequently observed in favorable tumors

Weak linkage at 4p16 to predisposition for human neuroblastoma

Genome-Wide Linkage Analysis to Identify Genetic Modifiers of <i>ALK</i> Mutation Penetrance in Familial Neuroblastoma ⬇️